Increased levels of the homeostatic chemokine CXCL13 in human atherosclerosis - Potential role in plaque stabilization.

[1]  Lasse Folkersen,et al.  Prediction of Ischemic Events on the Basis of Transcriptomic and Genomic Profiling in Patients Undergoing Carotid Endarterectomy , 2012, Molecular medicine.

[2]  C. Weber,et al.  Atherosclerosis: current pathogenesis and therapeutic options , 2011, Nature Medicine.

[3]  J. Cyster,et al.  Finding the right niche: B-cell migration in the early phases of T-dependent antibody responses. , 2010, International immunology.

[4]  Carl Nathan,et al.  Nonresolving Inflammation , 2010, Cell.

[5]  G. Getz,et al.  Lymphotoxin β receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE−/− mice , 2009, The Journal of experimental medicine.

[6]  F. Tacke,et al.  Protective Role of CXC Receptor 4/CXC Ligand 12 Unveils the Importance of Neutrophils in Atherosclerosis , 2008, Circulation research.

[7]  M. Meyer-Hermann,et al.  Mechanisms of organogenesis of primary lymphoid follicles. , 2006, International immunology.

[8]  Christian Weber,et al.  Ccr5 But Not Ccr1 Deficiency Reduces Development of Diet-Induced Atherosclerosis in Mice , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[9]  A. Chang,et al.  CXC Chemokine Ligand 13 and CC Chemokine Ligand 19 Cooperatively Render Resistance to Apoptosis in B Cell Lineage Acute and Chronic Lymphocytic Leukemia CD23+CD5+ B Cells1 , 2006, The Journal of Immunology.

[10]  I. Charo,et al.  Targeted Disruption of the Scavenger Receptor and Chemokine CXCL16 Accelerates Atherosclerosis , 2006, Circulation.

[11]  G. Hansson,et al.  Inflammation and atherosclerosis. , 2006, Annual review of pathology.

[12]  Lisa M. Ebert,et al.  Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues. , 2005, Molecular immunology.

[13]  M. Salmon,et al.  Chemokine receptors in the rheumatoid synovium: upregulation of CXCR5 , 2004, Arthritis research & therapy.

[14]  U. Höpken,et al.  The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity , 2003, Immunological reviews.

[15]  C. Weyand,et al.  Ectopic Germinal Center Formation in Rheumatoid Synovitis , 2003, Annals of the New York Academy of Sciences.

[16]  P. Debré,et al.  Decreased Atherosclerotic Lesion Formation in CX3CR1/Apolipoprotein E Double Knockout Mice , 2003, Circulation.

[17]  P. Libby,et al.  Progression of Atheroma: A Struggle Between Death and Procreation , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[18]  E. S. Baekkevold,et al.  B cell attracting chemokine 1 (CXCL13) and its receptor CXCR5 are expressed in normal and aberrant gut associated lymphoid tissue , 2002, Gut.

[19]  P. Loetscher,et al.  Homing chemokines in rheumatoid arthritis , 2002, Arthritis research.

[20]  I. Charo,et al.  Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis , 1998, Nature.

[21]  P. Libby,et al.  Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. , 1998, Molecular cell.

[22]  Jason G. Cyster,et al.  A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1 , 1998, Nature.

[23]  R. Terkeltaub,et al.  A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. , 1998, The Journal of clinical investigation.